CDH19 Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9H159 |
---|---|
Clone Names | 101008187 |
Gene ID | 28513 |
---|---|
Other Names | Cadherin-19, CDH19, CDH7L2 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | CDH19 |
---|---|
Synonyms | CDH7L2 |
Function | Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. |
Cellular Location | Cell membrane; Single-pass type I membrane protein |
Tissue Location | Expressed in many tissues, with the exception of uterus |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene is a type II classical cadherin from thecadherin superfamily and one of three cadherin 7-like genes locatedin a cluster on chromosome 18. The encoded membrane protein is acalcium dependent cell-cell adhesion glycoprotein comprised of fiveextracellular cadherin repeats, a transmembrane region and a highlyconserved cytoplasmic tail. Type II (atypical) cadherins aredefined based on their lack of a HAV cell adhesion recognitionsequence specific to type I cadherins. Since disturbance ofintracellular adhesion is a prerequisite for invasion andmetastasis of tumor cells, cadherins are considered primecandidates for tumor suppressor genes.
References
Need, A.C., et al. Hum. Mol. Genet. 18(23):4650-4661(2009)Clark, H.F., et al. Genome Res. 13(10):2265-2270(2003)Kools, P., et al. Genomics 68(3):283-295(2000)Shimoyama, Y., et al. Biochem. J. 349 (PT 1), 159-167 (2000) :Kremmidiotis, G., et al. Genomics 49(3):467-471(1998)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.